Franklin Fuh Selected Research

etrolizumab

10/2022	Correction to: Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Results from a Phase 1 Randomized Trial.
1/2022	Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Results from a Phase 1 Randomized Trial.
1/2019	Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease.
1/2018	Pharmacokinetic and Pharmacodynamic Modeling of Serum Etrolizumab and Circulating β7 Receptor Occupancy in Patients With Ulcerative Colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Franklin Fuh Research Topics

Disease

4	Ulcerative Colitis 10/2022 - 01/2018
3	Crohn Disease (Crohn's Disease) 10/2022 - 01/2019
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2019
1	Lymphoma (Lymphomas) 07/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2013
1	Neoplasms (Cancer) 07/2013
1	Chromosome Aberrations (Chromosome Abnormalities) 05/2008
1	Multiple Myeloma 05/2008

Drug/Important Bio-Agent (IBA)

4	etrolizumabIBA 10/2022 - 01/2018
2	IntegrinsIBA 11/2021 - 01/2019
1	Immunoconjugates (Immunoconjugate)IBA 07/2013
1	auristatinIBA 07/2013
1	Rituximab (Mabthera)FDA Link 07/2013
1	AntigensIBA 07/2013
1	Pharmaceutical PreparationsIBA 07/2013
1	pinatuzumab vedotinIBA 07/2013
1	Messenger RNA (mRNA)IBA 05/2008
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 05/2008
1	elotuzumabIBA 05/2008

Therapy/Procedure

2	Therapeutics 11/2021 - 01/2019
1	Combination Drug Therapy (Combination Chemotherapy) 07/2013